Take a look at our previous reports:

5. Segment information

Geographical information

In 2021 our continuing operations were mainly located in Belgium, France, the Netherlands, Germany, Italy, Spain, Switzerland and the United Kingdom and the revenues from our collaboration partner Gilead represented almost 100% of the collaboration revenues.

Following table summarizes our collaboration revenues by destination of customer:

 

Year ended 31 December,

(thousands of €)

2021

2020

United States of America

467,978

472,445

Europe

2,114

5,605

Total collaboration revenues

470,093

478,051

Following table summarizes our collaboration revenues by major customers:

 

Year ended 31 December,

 

2021

2020

 

(thousands of €)

%

(thousands of €)

%

Gilead

 

 

 

 

United States of America

467,978

100%

472,445

99%

Europe

2,071

0%

1,460

0%

Novartis

 

 

 

 

Europe

-

0%

4,125

1%

Total collaboration revenues from major customers

470,049

100%

478,030

100%

On 31 December 2021, we held €198 million (€171 million in 2020) of property, plant and equipment and intangible assets distributed as follows:

 

31 December

(thousands of €)

2021

2020

Belgium

98,295

113,524

France

21,051

18,398

The Netherlands

66,621

28,210

Switzerland

7,181

7,668

Spain

3,029

2,755

Other

1,438

388

Total

197,615

170,943